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http://dx.doi.org/10.1016/j.jmii.2013Background: Infants in a neonatal intensive care unit (NICU) have a higher incidence of blood-
stream infections (BSIs) than any other pediatric or adult population. The predisposing factors
have not been comprehensively evaluated in this population in Taiwan.
Methods: A retrospective matched case-control study was conducted in the NICUs of a teach-
ing hospital in Taiwan. The case patients were identified from a staff-maintained electronic
database containing the records of BSIs from July 2003 to June 2006. The case patients and
the control patients (who did not develop BSI during their NICU stay) were 1:1 matched by birth
weight, gestational age, gender, Apgar score, and date of birth.
Results: A total of 164 infants with culture-proven BSI were identified. Of these, 74 (45.1%) in-
fants were female. The mean gestational age and birth weight were 30.7  0.7 weeks and
1512  804 g, respectively. The common etiologic pathogens included coagulase-negative
staphylococci (28.7%), Staphylococcus aureus (16.5%), and Klebsiella pneumoniae (14.6%).
Candida spp. accounted for 11 (6.7%) episodes. Two independent factors associated with BSIs
in the neonates, as identified by multivariate analysis using conditional logistic regression,ediatric Infectious Diseases, Department of Pediatrics, Chang Gung Children’s Hospital, Number 5, Fu-
aiwan.
h.org.tw (C.-J. Chen).
to this work.
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Risk factors of neonatal sepsis 431were the use of parenteral nutrition (matched odds ratio [mOR], 6.07; 95% confidence interval
[CI], 1.14e32.32; pZ 0.034) and intraventricular hemorrhage (mOR, 2.68; 95% CI, 1.20e5.99;
p Z 0.017).
Conclusion: Parenteral nutrition was a significant and independent risk of late-onset neonatal
sepsis. This risk should be considered when implementing early parenteral nutrition in NICUs.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Neonatal bloodstream infections (BSIs) are an important
complication among premature infants in neonatal inten-
sive care units (NICU) all over the world.1 The invasive in-
fections can lead to severe morbidities and mortality,
prolong the length of hospitalization, and increase the cost
of medical care. Managing neonatal BSIs is a challenge for
physicians. In the past few decades, the mortality rate of
late-onset sepsis has remained at a high level (5e15%) in
most neonatal care facilities, despite with a declining
trend.2e6 The incidence of late-onset BSI on admission
differs in infants at certain gestational ages, birth weights,
gender, and conditions, and it is associated with various
invasive procedures performed during intensive care.3,7,8
To lessen the disease burden, it is essential to identify
potential risk factors, followed by effective preventive or
infection control measures.
In Taiwan, the incidence of neonatal late-onset BSIs
ranged from 4% to 11.4% with a mortality rate of
7.2e20%.7,9e11 The risk factors preceding BSIs were not
comprehensively evaluated in this population. To identify
the risk factors, we conducted a retrospective case-control
study in the NICUs of a teaching hospital.
Materials and methods
Ethics statement
The study was approved by the institute review boards from
Chang Gung Memorial Hospital (Taoyuan, Taiwan), which
allowed the retrieval of patient lists from the electronic
database and a retrospective review of the medical infor-
mation. A waiver of consent was granted because of the
retrospective nature of the project and the anonymous
analysis of the data.
Study design
A retrospective matched case-control study was performed
in the NICUs of Chang Gung Children’s Hospital (CGCH) from
July 1, 2003 to June 30, 2006. The CGCH is a 532-bed
teaching hospital in northern Taiwan that provides primary
to tertiary care for children younger than 18 years old. This
hospital has three NICUs with a total of 98 beds. Since 1 July
2003, an electronic database was established to routinely
collect the demographic data and information of several
predefined major events that occurred in each neonatepatient during her/his stay in the NICUs. The predefined
major events included BSIs; any surgery; intraventricular
hemorrhage; bronchopulmonary dysplasia; retinopathy of
prematurity; necrotizing enterocolitis; and all positive cul-
ture results (i.e., blood culture, urine culture, sputum cul-
ture), irrespective of their clinical relevance. All discharge
diagnoses were also collected. A well-trained nurse was
responsible for gathering these data on the day of patient
discharge by comprehensively reviewing the written and
electronic medical records. During the study period, a list
was retrieved from this database of the neonatal patients
who fulfilled the criteria of late-onset culture-proven BSIs
(discussed later). At a case-control ratio of 1:1, the case
infants were matched to control infants (who never devel-
oped BSI during their stay in NICU) by birth weight (250 g),
gestational age (2 weeks), gender, and date of birth (1
month). The medical records of the case infants and the
control infants were retrospectively reviewed. A standard-
ized data collection form was used to collect the clinical
information needed in this study. The data were digitized
and cleaned before we proceeded with statistical analysis.
Definition of late-onset culture-proven BSIs in the
neonates
The definition of late-onset neonatal BSI was adapted and
modified from the 2008 criteria of the National Nosocomial
Infection Surveillance System.12 Neonatal late-onset cul-
ture-proven BSI was defined when a recognized pathogen
was cultured from the blood of a patient older than 7 days
and was unrelated to an infection at another body site
(e.g., pneumonia with bacteremia). The BSIs of common
skin contaminants (e.g., diphtheroids, Bacillus, Propioni-
bacterium, coagulase-negative staphylococci, or micro-
cocci) were identified if the organism was cultured from
two or more blood cultures drawn on separate occasions or
from at least one blood culture from a patient with an
intravascular line and appropriate physician-instituted
antimicrobial therapy, and if the patient had at least one
of the following manifestations: fever (greater than 38C),
hypothermia (less than 37C), apnea, or bradycardia. In our
institute, the body temperature was measured by placing
the thermometer under the back of the infants.
Assessment of risk factors
We assessed the exposure to potential risk factors for BSI.
To avoid the influence of known general risks on the
occurrence of BSI, univariate and multivariate analyses
Table 1 Demographics, maternal comorbidities, perinatal
characteristics, and outcome of the case infants and the
control infants
Case infants
(N Z 164)
Control infants
(N Z 164)
p
Gestational age (wk) 30.7  4.2 31.5  4.5 0.333
Birth weight (g) 1512  804 1705  850 0.052
Patient source 0.119
Inborn (%) 69.6 58.6
Other hospitals (%) 25.6 37.0
ER or clinic (%) 4.8 4.3
Duration of risk
exposurea
30.7  37.6 28.5  60.0 0.684
PROM > 18 h (%) 24.2 23.2 0.840
Apgar scores at 5 min 7.5  1.9 7.9  1.8 0.052
Multiple gestation (%) 24 20.6 0.496
IUGR (%) 8 5.6 0.425
Perinatal infection (%) 6.4 3.75 0.304
Use of steroids (%) 35.3 21.25 0.009
Mortality (%) 6.4 13.7 0.053
a The value indicates the duration of patients at risk of
bloodstream infections. For the case infants, this is the period
of time before they developed a bloodstream infection; for the
control infants, this is the duration of the whole NICU stay.
ER Z emergency room; IUGR Z intrauterine growth retarda-
tion; PROM Z premature rupture of membranes.
Table 2 Bacterial species identified in 164 neonatal pa-
tients who had a bloodstream infection in a Taiwanese
teaching hospital during July 2003eJune 2006
Species No. of
episodes
%
Coagulase-negative staphylococci 47 28.7
Klebsiella pneumoniae 24 14.6
Methicillin-resistant
Staphylococcus aureus
21 12.8
Escherichia coli 12 7.3
Enterobacter cloacae 12 7.3
Acinetobacter baumannii 11 6.7
Candida albicans 8 4.9
Enterobacter aerogenes 7 4.2
Methicillin-sensitive
Staphylococcus aureus
6 3.7
Enterococcus faecalis 4 2.4
Klebsiella oxytoca 4 2.4
Candida parapsilosis 3 1.8
Pseudomonas aeruginosa 2 1.2
Hanfnia alvei 2 1.2
Viridans streptococcus 1 0.6
Total 164 100
432 Y.-H. Kung et al.were performed to control for factors such as gender,
maturity, and health condition at birth. The case infants
were assessed from their date of admission in the NICU to
the first culture-proven BSI. For the control infants, the
exposure to risk factors was determined from the date of
admission to the NICU until the date of discharge or death.
The collected potential risk factors consisted of: (1)
prenatal and maternal history such as toxemia, multiple
gestation, intra-uterine growth retardation, and perinatal
infections; (2) perinatal history such as premature rupture
of membrane greater than 18 hours and delay in initial
crying; (3) invasive procedures such as instrument insertion
and its duration (e.g., placement of nasogastric tubes,
endotracheal tubes, mechanical ventilation, peripherally
inserted central catheters, chest tubes, blood transfusion
or exchanged blood transfusion, and lumbar puncture); (4)
the concomitant use of medications such as parenteral
nutrition and intravenous lipid, antibiotics, and steroids;
(5) comorbidities such as meconium aspiration syndrome
(MAS), persistent pulmonary hypertension of the newborn
(PPHN), intraventricular hemorrhage (IVH), necrotizing
enterocolitis (NEC), respiratory distress syndrome (RDS),
inborn error of metabolism, and cardiac anomalies (except
for patent ductus arteriosis, and secundum type of atrial
septal defect).
Statistics
Each potential predictor was initially evaluated by univar-
iate analysis. The categorical variables were compared
with a c2 test or with the Fisher exact test, when appro-
priate. Differences among the numerical variables were
analyzed using a two-sample t test. Potential individual risk
factors at p < 0.05 were entered together into a set of final
conditional logistic regression model (Proc PHREG; SAS
version 9.1, SAS Institute Inc., Cary, NC, USA). Statistical
significance was defined as a p value of <0.05.
Results
Demographics and clinical characteristics
During the study period, 164 case infants and 164 control
infants were identified. Of the patients, 45.1% were female
and the mean  standard deviation of gestational age and
birth weight was 31.1  4.4 months and 1622  835 g,
respectively. Most (63.4%) patients were born in the hos-
pital. The demographic data did not differ significantly for
the case infants and the control infants (Table 1). The mean
duration of the NICU stay before developing BSI was
30.7  37.6 days for the case infants, which was similar to
the mean duration of NICU stay for the control infants
(pZ 0.684). The prenatal and perinatal characteristics and
illness severity of the two groups before admission were
also similar in the rates of premature rupture of membrane,
multiple gestation, intrauterine growth retardation, peri-
natal infections, and Apgar score at birth (Table 1). The
maternal use of steroids was the only exception, which was
more commonly identified in the case infants than in the
control infants (35.3% vs. 21.3%, respectively; p Z 0.009).
The mortality rate was higher for the control infants thanfor the case patients (13.7% vs. 6.4%, respectively), but the
difference was of borderline significance (p Z 0.053).
Table 3 Univariate analysis of procedures and comorbid-
ities associated with neonatal sepsis
Case
infants
(N Z 164)
Control
infants
(N Z 164)
p
Procedures
Placement of
NG tube (%)
96.8 86.6 0.003
Duration (d) 30.1  28.9 32.2  28.1 0.558
Intubation (%) 78.4 56.1 <0.001
Duration (d) 22.2  24.4 17.2  21.1 0.127
PICC line
placement (%)
81.6 53.1 <0.001
Duration (d) 27.7  28.4 23.8  17.1 0.241
Lumbar puncture (%) 6.4 11.0 0.216
Chest tube
placement (%)
19.2 16.5 0.641
Duration (d) 4.5  4.4 7.2  18.7 0.483
RBC transfusion (%) 65.6 59.8 0.329
PLT transfusion (%) 21.6 15.4 0.216
Parenteral
nutrition (%)
88.8 56.7 <0.001
Duration (d) 23.4  23.7 21.6  17.8 0.537
Intravenous lipid (%) 84.8 54.3 <0.001
Duration (d) 23.0  24.1 20.9  17.3 0.483
Use of extended
spectrum
beta-lactam
antibiotics (%)a
38.4 40.2 0.821
Use of
carbapenem (%)
6.1 7.3 0.826
Use of steroids (%) 14.4 14.2 0.571
Exchange blood
therapy (%)
4.0 1.96 0.474
Comorbidity
MAS (%) 1.6 0.61 0.580
PPHN (%) 2.4 0 1.000
RDS (%) 59.2 43.6 0.009
IVH (%) 21.6 10.5 0.013
Grade III or
IV IVH (%)
5.5 4.3 0.799
NEC (%) 4.0 4.3 1.000
Use of surfactant (%) 81.3 80 1.000
IEM (%) 1.6 0 0.188
Cardiac anomaly (%) 5.6 4.97 1.000
a The extended spectrum beta-lactams included cefotaxime,
ceftazidime, ceftriaxone, cefepime, flomoxef, piperacillin, and
piperacillin/tazobactam.
IEM Z inborn errors of metabolism; IVH Z intraventricular
hemorrhage; MAS Z meconium aspiration syndrome;
NEC Z necrotizing enterocolitis; PICC Z peripherally inserted
central catheter; PLTZ platelet; PPHNZ persistent pulmonary
hypertension; RBCZ red blood cell; RDSZ respiratory distress
syndrome.
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Among the 164 culture-proven BSIs, 79 (48.2%) episodes
were caused by Gram-positive organisms; 74 (45.1%) epi-
sodes, by Gram-negative organisms; and 11 (6.7%) episodes,
by Candida spp. (Table 2). The most common pathogen was
coagulase-negative staphylococci (28.7%), followed by
Klebsiella pneumonia (14.6%), and methicillin-resistant
Staphylococcus aureus (12.8%).
Univariate analysis of risk factors associated with
BSIs
In univariate analysis, an increased incidence of BSIs was
associated with the placement of a variety of instruments
or catheters such as nasogastric tubes (pZ 0.003), tracheal
intubation (p < 0.001), and percutaneously inserted central
catheters (p < 0.001) (Table 3). Infants also had higher risk
of BSIs if they received parenteral nutrition (p < 0.001) or
intrafat (p < 0.001), or if they developed RDS (p Z 0.009)
or intraventricular hemorrhage (IVH) (p Z 0.013). The
following factors were not associated with BSIs: trans-
fusion, antimicrobial treatment, use of steroids, and the
presence of other comorbidities (e.g., MAS, NEC, and car-
diac anomalies).
Multivariate analysis of factors associated with BSIs
The multivariate analysis using conditional logistic regres-
sion identified parenteral nutrition (matched odds ratio
[mOR], 6.07; 95% confidence interval [CI], 1.14e32.32;
p Z 0.034) and IVH (mOR, 2.68; 95% CI, 1.20e5.99;
p Z 0.017) as two significant factors that were indepen-
dently associated with BSIs. Prenatal use of steroids was
associated with a 1.82-fold increased risk of BSIs, although
this had no statistical significance (95% CI, 0.98-3.40;
p Z 0.059).
Discussion
Central venous catheter insertion and its duration of use
were the main risk factors of nosocomial BSI in premature
neonates.3,4,8,13e15 In the current study, a central venous
catheter (CVC) inserted at a peripheral site was more
frequently used in the septic infants than in the control
infants (81.6% vs. 53.1%, respectively; p < 0.001). However,
this significance disappeared after adjusting for other po-
tential risk factors and controlling for gender, maturity, and
the health status of the neonate at birth (pZ 0.579) (Table
4). This finding suggested that the use of CVC did not sub-
stantially increase the incidence of BSI when the premature
infants were of similar demographics and similar health
condition at birth.
The administration of parenteral nutrition was associ-
ated with approximately 6-fold greater risk of BSI. The risk
factor has also been identified in several previous reports.
Sohn et al4 reported a 5.7-fold relative risk in infants
receiving parenteral nutrition. Kawagoe et al8 demon-
strated a 4.0-fold higher risk of nosocomial infections in
neonates on parenteral nutrition. Parenteral nutrition hasbeen extensively used to maintain the nutritional condition
of critically ill neonates that are intolerable to or in
advancing on gastrointestinal feeding. Several plausible
theories have been suggested to explain the relationship
between parenteral nutrition and neonatal BSI. For
instance, an elemental diet and parenteral nutrition may
Table 4 Multivariate analysis of risk factors associated
with neonatal sepsis by using conditional logistic regression
in a matched case-control study
Predictors mOR 95% CI p
Prenatal use of steroids (%) 1.82 0.98e3.40 0.059
Placement of NG tube (%) 1.09 0.26e4.59 0.906
Intubation (%) 1.49 0.66e3.35 0.335
PICC line placement (%) 1.28 0.54e3.05 0.579
Parenteral nutrition (%) 6.07 1.14e32.32 0.034
Intrafat (%) 0.77 0.16e3.68 0.747
RDS 0.87 0.41e1.85 0.709
IVH (%) 2.68 1.20e5.99 0.017
CI Z confidence interval; IVH Z intraventricular hemorrhage;
mOR Z matched odds ratio; NG Z nasogastric; PICC Z
peripherally inserted central catheter; RDS Z respiratory
distress syndrome.
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translocation.16 Longterm parenteral nutrition utilization
would also impair host defense mechanisms and bacteri-
cidal activity.17 In recent years, experts have nevertheless
proposed commencing early post-natal parenteral nutrition
within 24 hours of birth for increasing positive nitrogen
balance, caloric intake and weight gain.18e20 Because of
the strong association of parenteral nutrition and bacter-
emia, we speculate the practice may increase the risk of
BSIs. This iatrogenic complication should be taken into
consideration when implementing this practice into the
routine care of preterm neonates.
Intraventricular hemorrhage (IVH) was another factor
independently associated with BSI in the current study. It is
possible that IVH may not be a risk factor preceding BSI; it
may instead be a consequence of BSI. Sepsis concomitant
with other factors (e.g., low birth weight, young gesta-
tional age, mechanical ventilation, and hypotension) is
known to significantly increase the risk of IVH in preterm
newborns.21 This finding corroborates the need for early
and frequent evaluation of the brain of preterm neonates
with sepsis.
The prenatal use of steroids was not statistically signif-
icant in the analysis of risk factors of neonatal BSI, although
we did find a trend toward a higher incidence of BSIs in
infants exposed to steroid treatment before birth. Steroid
treatment is often used prenatally to accelerate lung
maturation in preterm infants and it is able to decrease
neonatal morbidities and mortality.22,23 Potential adverse
consequences nevertheless were also reported, which
included increased incidence of neonatal and maternal in-
fections, especially among patients who received multiple
courses of prenatal steroids.23 The potential harm of the
steroid administration should be considered in the prenatal
care of mothers at risk of premature birth.
In this study, the mortality rate was 6.4% for the case
infants, which was lower than the rate for the control in-
fants (13.7%), and was of borderline significance
(p Z 0.053). This finding was unexpected and should be
interpreted with caution. The observation may result from
a possible selection bias, which was caused by the
nonrandom method of selecting the control infants. Thestudy was not designed to address the impact of infection
on the outcome, and potential outcome-related factors
were not controlled in the comparison. It was not adequate
to draw any conclusion regarding to the impact of BSI on the
outcome of NICU patients in the current study.
There were several limitations in this study. First, this
was a single center study and the identified factors of BSI
may not be generalized to other institutions. The sample
size was relatively small and some potential risk factors
may not have been readily identified. However, the risks
that are already identified should remain significant and
should not be severely affected by the sample size. Second,
coagulase-negative staphylococci were the most common
organisms accounting for neonatal sepsis in our NICUdthis
was consistent with previous reports.4,5,9,24 It was difficult
to clarify the clinical relevance of the normal skin flora
when the organisms were isolated from blood cultures in
NICU settings.25 Although strict criteria were applied to
define the neonatal BSI by the skin flora, we were unable to
completely rule out the possibility that some case patients
infected with coagulase-negative staphylococci may actu-
ally not have true infections. Third, the control infants
were not randomly selected, which may have led to a se-
lection bias and possibly affected the significance of the
risk factors.
The methods to prevent neonatal BSI include improved
handwashing, aseptic manipulation, ameliorated feeding
strategies, care bundles against common nosocomial in-
fections (e.g., methicillin-resistant Staphylococcus aureus
[MRSA]), nasal screening of resistant strains, and in-
terventions such as prophylactic antibiotics.26 Data from
the current study highlighted the importance of re-
evaluating the indication, administration, and preparation
of parenteral nutrition. Every attempt should be applied to
minimize the duration of parenteral nutrition and
encourage early enteral feeding.
In conclusion, we demonstrated thatdafter controlling
for gender, birthweight andApgar scores, the administration
of parenteral nutrition, and possibly the prenatal use of
steroids remained significant predictors of neonatal BSIs. The
identified factors can be generalized to the preterm neo-
nates, regardless of their demographic characteristics.
The recognition of risk factors should help in developing
a preventive strategy against BSIs and would ultimately
promote the quality of care for preterm infants. The find-
ings should also help reshape the policy and practice in
NICUs regarding the timing of parenteral nutrition and may
reduce the burden of BSIs in neonates.
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